Article

A Precision Medicine Approach to Metabolic Therapy for Breast Cancer in Mice

2021-12-16

Abstract excerpt

Increasing evidence highlights the possibility for approaches targeting metabolism as potential adjuvants to cancer therapy. Sodium-glucose transport protein 2 (SGLT2) inhibitors are the newest class of antihyperglycemic therapies, and have recently been highlighted as a novel therapeutic approach to breast cancer. To our knowledge, however, SGLT2 inhibitors have not been applied in the neoadjuvant setting as a pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 37a715d5-3bac-50b7-8af0-419ba6a64813
DOI: 10.1101/2021.12.15.472809

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Precision Medicine Approach to Metabolic Therapy for Breast Cancer in MiceDOI 10.1101/2021.12.15.472809Read

Metabolic reprogramming to optimise breast cancer treatmentSemantic proximity Read

Knockdown of PGM1 Synergistically Enhances Anticancer Effects of Orlistat in Gastric Cancer Under Glucose DeprivationSemantic proximity Read

Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer XenograftsSemantic proximity Read

Tumor Cytokine-Induced Hepatic Gluconeogenesis Contributes to Cancer Cachexia: Insights from Full Body Single Nuclei SequencingSemantic proximity Read

miR-526b dysregulates glucose metabolism via the COX2/EP4 pathwaySemantic proximity Read

Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment.Semantic proximity Read

Developing the Theory of Toxic Chemotherapeutic Nutrition for Cancer Cells and Targeting Tumors via Glucose Mutation: Medical Guidance and Integrated Therapeutic ApproachSemantic proximity Read

Developing the theory of Toxic Chemotherapeutic Nutrition for Cancer Cells: Glucosodiene Polymer Structure, Safety, Efficacy, and Human Outcomes in Targeting Tumors via Glucose Mutation.Semantic proximity Read

Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.Semantic proximity Read

LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancerSemantic proximity Read

Targeting PI3K inhibitor resistance in breast cancer with metabolic drugsSemantic proximity Read

Targeting AMPK for Cancer Therapy: Metabolic Reprogramming as a Therapeutic StrategySemantic proximity Read